USPTO serial 88675262
CSL BEHRING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 1, 2022
- Examiner
- JENKINS JR, CHARLES L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CSL BEHRING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
King of Prussia, PA
King of Prussia, PA
King of Prussia, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST. NW, SUITE 400WASHINGTON, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for blood diseases, illnesses and conditions; Pharmaceutical preparations for the treatment or prevention of blood and bleeding disorders; diagnostic preparation for medicinal purposes | ACTIVE | — |
| 009 | Electronic publications, namely, newsletters and manuals featuring medical information and health treatment information recorded on computer media; Downloadable educational course materials in the field of health and medical treatment | ACTIVE | — |
| 010 | Apparatus of blood analysis; blood testing apparatus | ACTIVE | — |
| 016 | Printed matter, namely, printed periodicals, newsletters, and brochures all in the fields of health, medicine and pharmaceuticals; publications, namely, hand-outs in the fields of health, medicine, treatment and pharmaceuticals; Printed instructional, educational, and teaching materials in the field of health, medicine, pharmaceuticals and treatment; Informational flyers featuring health, medicine, pharmaceuticals and treatment information; Brochures about health, medicine, pharmaceuticals and treatment; Pamphlets in the field of health, medicine, pharmaceuticals and treatment information; posters; instruction sheets in the field of health, medicine, pharmaceuticals and treatment; Printed instructional, educational, and teaching materials in the field of health, medicine, pharmaceuticals and treatment | ACTIVE | — |
| 035 | Provision of information relating to wholesale and retail services in the pharmaceutical industry; Provision of information relating to promotion services in the field of promoting awareness of blood diseases, illnesses and conditions and treatment or prevention of blood and bleeding disorders, and promoting awareness of pharmaceutical and health treatments | ACTIVE | — |
| 040 | Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of biological products, namely, custom manufacturing and fractionation of blood; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma | ACTIVE | — |
| 041 | Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment | ACTIVE | — |
| 042 | Scientific and technological research, namely, scientific testing and screening services, testing of human blood plasma for safety and quality; research and development of scientific, medical, pharmaceutical and blood products; Product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals; management of scientific research projects, namely, conducting scientific research; Pharmaceutical research services; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma | ACTIVE | — |
| 044 | Medical information services; health care information services; medical diagnostic testing, monitoring and reporting services; patient support services, namely, providing information to patients in the field of administering medications; medical information concerning pharmaceuticals, medical products and blood products; Medical testing for diagnostic or treatment purposes; medical testing of human blood plasma; collection, processing and testing of human blood and plasma for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CSL Behring LLC
- Other trademarks owned by CSL Behring LLC
- Other trademarks owned by CSL Behring LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CSL BEHRING
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 5, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 3, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 1, 2021 | PBMR | WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST | — |
| Sep 27, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 13, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 13, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 13, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 13, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 13, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 13, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2019 | NWAP | NEW APPLICATION ENTERED | — |